Kumar Neil bought BBIO
August 16, 2025 · Form 4 insider transaction
Kumar Neil bought 64,697 shares of BridgeBio Pharma, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
64,697
Price
N/A
Total value
N/A
InsiderKumar Neil
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 16, 2025
Filing dateAugust 19, 2025
Shares owned after282,101
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.